The various COVID-19 vaccine rollout phases impacted the prevalence of depression and anxiety at the population level among adults in the country.
Ji Xing buys Biogen’s acute ischemic stroke drug; Exelixis/BioInvent partnership ends; ClinChoice’s deal in SEA
Ji Xing acquires Biogen’s experimental therapy for acute ischemic stroke: The Shanghai-based biopharma did not disclose the financial terms of the deal. Back in 2018,